Szentesi P, Bekedam M A, van Beek-Harmsen B J, van der Laarse W J, Zaremba R, Boonstra A, Visser F C, Stienen G J M
Dept. of Physiology, VU Medical Center, Amsterdam, The Netherlands.
J Appl Physiol (1985). 2005 Dec;99(6):2189-95. doi: 10.1152/japplphysiol.00542.2005. Epub 2005 Jul 28.
Isometric force production and ATPase activity were determined simultaneously in single human skeletal muscle fibers (n = 97) from five healthy volunteers and nine patients with chronic heart failure (CHF) at 20 degrees C. The fibers were permeabilized by means of Triton X-100 (1% vol/vol). ATPase activity was determined by enzymatic coupling of ATP resynthesis to the oxidation of NADH. Calcium-activated actomyosin (AM) ATPase activity was obtained by subtracting the activity measured in relaxing (pCa = 9) solutions from that obtained in maximally activating (pCa = 4.4) solutions. Fiber type was determined on the basis of myosin heavy chain isoform composition by polyacrylamide SDS gel electrophoresis. AM ATPase activity per liter cell volume (+/-SE) in the control and patient group, respectively, amounted to 134 +/- 24 and 77 +/- 9 microM/s in type I fibers (n = 11 and 16), 248 +/- 17 and 188 +/- 13 microM/s in type IIA fibers (n = 14 and 32), 291 +/- 29 and 126 +/- 21 microM/s in type IIA/X fibers (n = 3 and 5), and 325 +/- 32 and 205 +/- 21 microM/s in type IIX fibers (n = 7 and 9). The maximal isometric force per cross-sectional area amounted to 64 +/- 7 and 43 +/- 5 kN/m(2) in type I fibers, 86 +/- 11 and 58 +/- 4 kN/m(2) in type IIA fibers, 85 +/- 6 and 42 +/- 9 kN/m(2) in type IIA/X fibers, and 90 +/- 5 and 59 +/- 5 kN/m(2) in type IIX fibers in the control and patient group, respectively. These results indicate that, in CHF patients, significant reductions occur in isometric force and AM ATPase activity but that tension cost for each fiber type remains the same. This suggests that, in skeletal muscle from CHF patients, a decline in density of contractile proteins takes place and/or a reduction in the rate of cross-bridge attachment of approximately 30%, which exacerbates skeletal muscle weakness due to muscle atrophy.
在20摄氏度下,对来自5名健康志愿者和9名慢性心力衰竭(CHF)患者的单根人体骨骼肌纤维(n = 97)同时测定等长力产生和ATP酶活性。通过Triton X-100(1%体积/体积)使纤维通透化。通过将ATP再合成与NADH氧化的酶促偶联来测定ATP酶活性。通过从最大激活(pCa = 4.4)溶液中测得的活性减去在松弛(pCa = 9)溶液中测得的活性,得到钙激活的肌动球蛋白(AM)ATP酶活性。根据肌球蛋白重链同工型组成,通过聚丙烯酰胺SDS凝胶电泳确定纤维类型。在对照组和患者组中,每升细胞体积的AM ATP酶活性(±SE),I型纤维分别为134±24和77±9微摩尔/秒(n = 11和16),IIA型纤维为248±17和188±13微摩尔/秒(n = 14和32),IIA/X型纤维为291±29和126±21微摩尔/秒(n = 3和5),IIX型纤维为325±32和205±21微摩尔/秒(n = 7和9)。对照组和患者组中,I型纤维每横截面积的最大等长力分别为64±7和43±5千牛/平方米,IIA型纤维为86±11和58±4千牛/平方米,IIA/X型纤维为85±6和42±9千牛/平方米,IIX型纤维为90±5和59±5千牛/平方米。这些结果表明,在CHF患者中,等长力和AM ATP酶活性显著降低,但每种纤维类型的张力消耗保持不变。这表明,在CHF患者的骨骼肌中,收缩蛋白密度下降和/或横桥附着速率降低约30%,这加剧了由于肌肉萎缩导致的骨骼肌无力。